Grace M. Lee

发表

Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines

E. Belongia, R. Harpaz, Manisha Patel, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines

E. Belongia, R. Harpaz, Manisha Patel, 2018, MMWR. Morbidity and mortality weekly report.

Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age.

Sophia R. Newcomer, J. Nelson, J. Glanz, 2013, JAMA pediatrics.

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

J. Gargano, B. Bell, Heather M. Scobie, 2021, MMWR. Morbidity and mortality weekly report.

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices

N. Calonge, A. Qaseem, M. Savoy, 2018, MMWR. Morbidity and mortality weekly report.

Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices

J. Iskander, A. Cohn, K. Kretsinger, 2006, MMWR Recommendations and Reports.

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020

B. Bell, M. Chamberland, J. Romero, 2020, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021

B. Bell, M. Chamberland, M. Daley, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020

B. Bell, M. Chamberland, J. Romero, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020

J. Gargano, B. Bell, M. Chamberland, 2020, MMWR. Morbidity and mortality weekly report.

Tetanus-diphtheria-acellular

J. Thomas, Grace M. Lee, A. Courtney, 2008 .

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022

C. Forrest, D. Christakis, M. Ritchey, 2022, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020

B. Bell, M. Chamberland, J. Romero, 2020, MMWR. Morbidity and mortality weekly report.

Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents: an exploratory EHR-based cohort study from the RECOVER program

C. Forrest, A. Mejias, D. Christakis, 2022, medRxiv.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

J. Gargano, B. Bell, Heather M. Scobie, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

B. Bell, M. Chamberland, M. Daley, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020

J. Gargano, B. Bell, M. Chamberland, 2021, MMWR. Morbidity and mortality weekly report.

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022

R. Link-Gelles, B. Bell, M. Daley, 2022, MMWR. Morbidity and mortality weekly report.

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

B. Bell, A. Fiore, M. Wharton, 2022, MMWR. Morbidity and mortality weekly report.

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

E. Woo, K. Ess, M. Wharton, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021

J. Gargano, B. Bell, Heather M. Scobie, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022

Sarah A. Meyer, R. Link-Gelles, B. Bell, 2011, MMWR. Morbidity and mortality weekly report.

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021

J. Gargano, M. Daley, H. Talbot, 2021, MMWR. Morbidity and mortality weekly report.

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

J. Gargano, Heather M. Scobie, M. Wharton, 2021, MMWR. Morbidity and mortality weekly report.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Miwako Kobayashi, T. Pilishvili, A. Leidner, 2019, MMWR. Morbidity and mortality weekly report.

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

C. Kotton, N. Masters, T. Anderson, 2022, MMWR. Morbidity and mortality weekly report.

Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults

L. Prosser, K. Dooling, A. Leidner, 2022, Human vaccines & immunotherapeutics.

Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022

C. Kotton, T. Anderson, K. Dooling, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.

R. Link-Gelles, B. Bell, H. Talbot, 2022, MMWR. Morbidity and mortality weekly report.

Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.

S. Greene, H. Tseng, Grace M. Lee, 2012, Vaccine.

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022

Sarah A. Meyer, B. Bell, H. Talbot, 2022, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020

B. Bell, M. Chamberland, J. Romero, 2020, American Journal of Transplantation.

Leveraging Serologic Testing to Identify Children at Risk For Post-Acute Sequelae of SARS-CoV-2 Infection: An Electronic Health Record–Based Cohort Study from the RECOVER Program

A. Mejias, D. Christakis, R. Jhaveri, 2022, The Journal of Pediatrics.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis

M. Proschan, N. Lurie, S. Greene, 2013, The Lancet.

Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.

S. Omer, T. Cheetham, J. Nordin, 2016, Vaccine.

J. Iskander, A. Cohn, K. Kretsinger, 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Maternal Tdap vaccination: Coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013.

S. Omer, T. Cheetham, J. Nordin, 2016, Vaccine.

Pediatric Nirmatrelvir/Ritonavir Prescribing Patterns During the COVID-19 Pandemic

C. Forrest, D. Christakis, R. Jhaveri, 2022, medRxiv.